spacer
home > pmps > autumn 2008 > rubber stoppers: delivering safe sterile components
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Rubber Stoppers: Delivering Safe Sterile Components

Supplying ‘ready-to-use’ primary packaging components is the logical follow-up to supplying ‘ready-to-sterilise’ components. By transferring washing and sterilisation operations to the supplier, this concept gives greater flexibility to pharmaceutical laboratories. Delegating a key operation like sterilisation requires the highest degree of quality assurance, and it is the responsibility of the supplier to guarantee the sterility of the parts it supplies. Obtaining sterile components requires mastery of all the applicable pharmaceutical requirements, control over the process before irradiation, and a validation procedure to ensure effective sterilisation.

MASTERY OF THE PRODUCTION PROCESS BEFORE IRRADIATION

Sterile, ‘ready-to-use’ products, whether stoppers or plungers, undergo a specific manufacturing process before being sterilised by gamma radiation...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >>

White Papers

Tightening Your Supply Chain Against Counterfeits

World Courier

As today’s global pharmaceutical supply chain grows increasingly longer and more complex, each link provides added opportunity for counterfeiters. While pending regulatory changes promise to tighten the supply chain with respect to production and distribution entities and new packaging technologies will make the identification of counterfeit products easier, the logistics of global distribution remains a weak link. How can the pharmaceutical shipper ensure the security of the supply chain over thousands of miles and extended periods of time when the product is no longer in his possession?
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement